United Kingdom Gene Editing Technology Business and Investment Opportunities Databook - Q2 2023 Update

According to the publisher, United Kingdom gene editing technology market size is expected to record a CAGR of 21.2% during 2023-2027 to reach US$0.459 billion by 2027, increasing from US$0.175 billion in 2023. Over the last five years, the sector has recorded a CAGR of 27.1% to reach US$0.138 billion in 2022.

This report provides an in-depth data-centric analysis of the emerging opportunities in gene editing industry. It covers a detailed view of market size and forecast across various segments such as gene editing technologies (CRISPR, meganucleases, TALEN, and ZFN), by products, delivery method, disease/disorders, and application.

This databook is a part of the title “Global Gene Editing Technology Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update”.

Scope

This report provides an in-depth, data-centric analysis of the United Kingdom gene editing market 2018-2027. Below is a summary of key market segments:

By Technology

• CRISPR CAS 9
• TALENs
• ZFN
• Others (Meganucleases)

By CRISPR PRODUCTS

• Kits & Enzymes
• Cell lines & Antibodies
• Others (Plasmid, Controls)

By TALENs PRODUCTS

• Kits & Enzymes
• Cell lines & Antibodies
• Others (Plasmid, Controls)

By ZFNs PRODUCTS

• Kits & Enzymes
• Cell lines & Antibodies
• Others (Plasmid, Controls)

By Meganucleases PRODUCTS

• Kits & Enzymes
• Cell lines & Antibodies
• Others (Plasmid, Controls)

By Delivery Method

• Ex-vivo
• In-vivo

By Disease/Disorders

• Cancer
• Blood Disorders (beta-thalassemia and sickle cell disease)
• Blindness
• Respiratory Disease (COVID-19 & Cystic fibrosis)
• Others (AIDS, Huntington’s disease, Muscular dystrophy)

By Application

• Drug Development
• Diagnostics
• Plant Gene Editing
• Others (Animal Gene Editing)

By End-User

• Pharmaceutical and Biopharmaceutical Companies
• Biotechnology Companies
• Contract Research Organisations
• Academic Institutes and Research Centres

Reasons to buy

• In-depth understanding of gene editing market dynamics: Understand market opportunity, industry dynamics, key trends, and drivers across different market segments and sub-segments of the industry in United Kingdom.
• Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
• Get market share analysis by end users: Get a detailed analysis across different end users such as pharmaceutical, biotechnology companies, academic & research institutes, and contract research organisations.